Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-201468

Options or other derivatives

  • Director acquired 64,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lehrer-Graiwer Joshua Director 2026-04-23 Grant or award · Stock Option (right to buy) +64,000 64,000 D
Loading xslF345X06/ownership.xml…